A systematic review and meta-analysis of seroprevalence of SARS-CoV-2 in Africa
This systemic review, released in a preprint that has not yet been peer reviewed, estimated that seroprevalence in Africa (due to infection or vaccination) rose from 3% in Q2 2020 to 65.1% in Q3 2021.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed